Janux Therapeutics, Inc. (JANX)
Across 20 earnings reports since Aug 10, 2021, Janux Therapeutics, Inc. (JANX) has a clear post-earnings pattern. It moves ±3.99% on average after reporting and finishes higher 55.0% of the time. Its largest post-earnings gain was +11.88% (Aug 09, 2022) and its largest decline was -9.49% (Mar 18, 2022). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings reactions
How JANX moved on each past earnings report.
Earnings Impact
Total Earnings
20
Avg Abs. Movement
±3.99%
Positive %
55.0%
Negative %
45.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 07, 2026 | ☽ POST | -2.44% | open_in_new |
| Feb 26, 2026 | ☽ POST | -1.38% | open_in_new |
| Nov 06, 2025 | ☽ POST | -7.61% | open_in_new |
| Aug 07, 2025 | ☽ POST | +1.11% | open_in_new |
Earnings Count
20
Total earnings in dataset
Avg Abs. Movement
±3.99%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260710 | open_in_new SEC.gov |
| 8-K | 20260623 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 4 | 20260612 | open_in_new SEC.gov |
| 8-K | 20260612 | open_in_new SEC.gov |
Frequently asked about JANX earnings
When does Janux Therapeutics, Inc. report earnings next? expand_more
Janux Therapeutics, Inc. (JANX)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does JANX stock move after earnings? expand_more
Over 20 reports, JANX has moved an average of ±3.99% the session after earnings, closing higher 55.0% of the time.
What was JANX's biggest post-earnings move? expand_more
JANX's largest post-earnings gain on record was +11.88% on Aug 09, 2022, and its largest decline was -9.49% on Mar 18, 2022.
Where can I find Janux Therapeutics, Inc.'s SEC filings? expand_more
All of Janux Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALAMO GROUP INC (ALG) earnings 2026-08-04
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04
- ProFrac Holding Corp. (ACDC) earnings 2026-08-07